Understanding the characteristics of L-ascorbic acid-montmorillonite nanocomposite: Chemical structure and biotoxicity

Biomedical Engineering - Applications, Basis and Communications

Volumn 18, Issue 1, 2006, Pages 30-36

  Chen, Bor Yann ^a   Lee, Yuan Haun ^b   Lin, Wu Ching ^b   Lin, Feng Huei ^b   Lin, King Fu ^b  

^a NATIONAL ILAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Dose response analysis; L ascorbic acid (LAA); Montmorillonite; Saccharomyces cerevisiae

Indexed keywords

INFRARED SPECTROSCOPY; LATTICE VIBRATIONS; MICROORGANISMS; ORGANIC ACIDS; PATIENT TREATMENT; PH; RISK ASSESSMENT; SILICON COMPOUNDS; STRUCTURE (COMPOSITION); TOXIC MATERIALS; X RAY DIFFRACTION ANALYSIS;

DOSE-RESPONSE ANALYSIS; L-ASCORBIC ACID (LAA); MONTMORILLONITE; SACCHAROMYCES CEREVISIAE;

NANOSTRUCTURED MATERIALS;

ANTINEOPLASTIC AGENT; ASCORBIC ACID; DRUG CARRIER; FLUOROURACIL; MONTMORILLONITE;

ARTICLE; CANCER CHEMOTHERAPY; CHEMICAL STRUCTURE; COLORECTAL CANCER; DOSE RESPONSE; FOURIER TRANSFORMATION; INFRARED SPECTROSCOPY; MICROORGANISM; NONHUMAN; RISK ASSESSMENT; SACCHAROMYCES CEREVISIAE; SCANNING ELECTRON MICROSCOPY; TOXICITY TESTING; X RAY DIFFRACTION;

SACCHAROMYCES CEREVISIAE;

EID: 33645506474     PISSN: 10162372     EISSN: None     Source Type: Journal    
DOI: 10.4015/S1016237206000075     Document Type: Article

References (29)

1. E. G. Ralph, Clay Mineralogy 2nd ed., McGraw-Hill, New York, 39-41 (1968).
2. Y. Laibin, B. Roth Charles, F. Low Philip, "Changes in the Si-O Vibrations of Smectite Layers Accompanying the Sorption of Interlayer Water." Langmuir, 12 (18), 4421-4429, (1996).
3. F. H. Lin, Y. H. Lee, C. H. Jian, J. M. Wong, M. J. Shieh, C. Y. Wang, "A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrier" Biomaterials 23, 1981-1987 (2002).
4. C. Heidelberger, N. K. Chaudhuari, P. Danenberg, "Fluorinated pyrimidines: a new class of tumor inhibitory compounds." Nature 179, 663-666 (1957).
5. N. J. Meropol, P. J. Creaven, N. J. Petrelli, "Metastatic colorectal cancer: advances in biochemical modulation and new drug development", Seminar Oncology, 22, 509-524 (1995).
6. Y. H. Lee, T. F. Kuo, B. Y. Chen, Y. K. Feng, Y. R. Wen, W. C. Lin , F. H. Lin, "Toxicity Assessment of Montmorillonite as a Drug Carrier for Pharmaceutical Applications: Yeast and Rats Model." Biomedical Engineering Applications, Basis and Communications, 17(2), 12-18 (2005).
7. Z. Borovec, "Distribution of toxic metals in stream sediments." Chem. Geol., 32, p.45-58 (1981).
8. B. Allard, G. W. Beall, T. Krajewski, J. Radioanal. Nucl. Chem. "Mineral-Contributed Anion Effects on the Retention of Trivalent Actinides in the Environment." 200, p.529 (1995).
9. L. J. Machlin, Handbook of Vitamins, 2nd Ed.; Marcel Dekker, Inc. (1991).
10. A. Bossi, S. A. Piletsky, E. V. Piletska, P. G. Rightti, Turner, A., and Anthony P. F., "An Assay for Ascorbic Acid Based on Polyaniline-Coated Microplates." Anal Chem. 72, 4296 (2000).
11. I. Yamamoto, A. Tai, Y. Fujinami, K. Sasaki, S. Okazaki, "Synthesis and characterization of a series of novel monoacylated ascorbic acid derivatives, 6-O-acyl-2-O-alpha-D-glucopyranosyl-L-ascorbic acids, as skin antioxidants." J. Med. Chem. 45, 462 (2002).
12. R. Austria, A. Semenzato, A. Bettero, "Stability of vitamin C derivatives in solution and topical formulations." J. Pharm. Biomed. Anal. 15, 795 (1997).
13. M. Gallarate, M. E. Carlotti, M. Trotta, S. Bovo, "On the stability of ascorbic acid in emulsified systems for topical and cosmetic use." Int. J. Pharm., 188, 233 (1999).
14. A. Semenzato, R. Austria, C. Dall' Aglio, A. Bettero, "HPLC determination of ionic compounds in cosmetic emulsions: Application to magnesium ascorbyl phosphate." J. Chromatogr. A 705, 385 (1995).
15. A. H. Rose, J. S. Harrison, The Yeasts, p. 300, 2nd ed., Academic Press, London (1987).
16. E. W. Charles, The chemistry of clay minerals, Oxford Press, New York (1975).
17. B. B. Zvyagin, Z. G. Pinsker, Structure of Montmorillonite, C. R. Acad. Sci. U.R.S.S., 68, 505-508 (1949).
18. J. Mering, R. Glaeser, "Cations enchangeables dans montmorillonite," C. R. Bull. 5, 61-72 (1953).
19. B. Y. Chen, H. L. Liu, Y. W. Chen, Y. C. Cheng, "Dose-response assessment of metal toxicity upon indigenous Thiobacillus thiooxidans BCl." Process Biochemistry. 39, 735-745 (2004).
20. G. W. Brindley, G. Brown (Eds.), "Crystal Structures of Clay Minerals and their X-Ray Identification." Mineralogical Society, Vol. 5, Chapter 8, London, 197-248, (1980).
21. R. Marc, "Flourine Route Synthesis of Montmorillonites containing Mg or Zn and Characterization by XRD, Thermal analysis, MAS NMR, and EXAFS spectroscopy." Eur. J. Inorg. Chem., Vol. 2001, Issue 11, 2831-2841 (2001).
22. J. Madejova, J. Bujdak, M. Janek, P. Komadel, "Comparative FT-IR study of structure modifications during acid treatment of dioctahedral smectites and hectorite." Spectrochimica Acta Part A, 54, 1397-1406 (1998).
23. R. L. Frost, L. Rintoul, "Lattice vibrations of montmorillonite: an FT Raman and X-ray diffraction study." Applied Clay Science 11, 171-183 (1996).
24. J. Madejova, "FTIR techniques in clay mineral studies", Vibrational Spectrosc., 31, 1-10 (2003).
25. M. Kozak, L. Domka, "Adsorption of the quaternary ammonium salts on montmorillonite." Journal of Physics and Chemistry of Solids 65, 441-445 (2004).
26. B. D. Michael, A. John, A. P. David, "VITAMIN C: Its Chemistry and Biochemistry." Royal Society of Chemistry, Paperbacks, Cambridge 38-40, (1991).
27. M. A. Ottoboni, Chapter 8 Chronic toxicity. In: The Dose makes the Poison 2nd Ed. p.79-90, Van Nostrand Reinhold, ITP, New York (1997).
28. B. Y. Chen, J. S. Chang, "Phenol Degradation and Toxicity Assessment upon Biostimulation to an indigenous Rhizobium Rastonia taiwanesis." Biotechnol. Prog. 21, 1085-1092 (2005).
29. B. Y. Chen, C. H. Wu, J. S. Chang, "An assessment of the toxicity of metals to Pseudomonas aeruginosa PU21 (Rip64)" In press, Bioresour. Technol. (2005).